Biohaven_BHV1530-101 (Advanced or Metastatic Solid Tumors) - Clinical Trial

¿Cuál es el Propósito de este estudio?

We are doing this study to find the most effective, safe dose of an experimental drug called BHV-1530 (the study drug) for adults who have advanced or metastatic solid tumors.

¿Cuál es la Condición que se está estudiando?

Advanced or Metastatic Solid Tumors

¿Quién puede participar en el Estudio?

Adults ages 18+ who:

Have a solid tumor form of cancer
Have disease that is locally advanced/metastatic and has not responded to therapy or come back after therapy

For more information, contact the study team at hollie.watson@duke.edu.

Grupo etario

Adultos

¿Qué Implica?

Si elige unirse a este estudio, podrá:

Get the study drug as an intravenous (IV) infusion every 3 weeks
Have study visits between drug infusions that might include the following procedures: physical exams, echocardiograms, imaging scans (CT or MRI), eye exams, or tumor tissue sampling

You will get the study drug for as long as the study doctor believes that you are getting a benefit. The dose of the study drug that is given will vary depending on when you join the study.

Detalles del Estudio

Título Completo

A Phase 1, Multicenter, Open-Label, Dose Escalation, Dose Expansion and Dose Confirmation Study of BHV-1530 in Adult Participants with Advanced or Metastatic Solid Tumors

Investigador Principal